Table 2.

Adherence rates.

Therapy	N observations per year over 2 years	Median adherence rate	IQR (25–75)
Immunomodulators
Total group	160	88%	58 to 100
Crohn's	120	88%	58 to 100
UC	40	87%	58 to 100
5-ASA
Total group	72	82%	49 to 100
Crohn's	18	92%	46 to 100
UC	54	81%	49 to 100
Anti-TNFα
Total group	80	100%	83 to 100
Crohn's	63	100%	82 to 100
UC	17	100%	86 to 100
Blood work
Total group	250	67%	42 to 100
Crohn's	159	67%	42 to 92
UC	91	67%	33 to 100